Zeta Global: Cautious Due To Unfavorable Growth Composition And Pricey M&A (Archive) Strong growth, ARPU-led expansion, pricey M&A and fair valuation drive a cautious Hold.
IonQ: This Quantum Computing Stock Has Stronger Fundamentals But Is Priced Dearly (Archive) IonQ’s commercial-first strategy delivers rapid growth but leaves shares trading at demanding valuations.
Celestica: A Trifecta Of Growth, Margin Expansion And Improving Cash Flow Conversion (Archive) Celestica delivers rare simultaneous strength in growth, margin expansion and cash flow conversion.
Meta: I Missed The Boat But Still Hesitant To Jump In Now (Archive) Meta’s slowing ad momentum and regulatory wildcard temper otherwise attractive valuation support.
Pfizer: Why I'm Staying On The Sidelines (Archive) Staying on the sidelines despite oncology progress and valuation discount.
Ares Capital: Bullish Due To Higher Deal Activity (Archive) Bullish on Ares Capital as record deal flow and floating-rate mix drive upside potential.
Microsoft: Backdated Azure Growth And Pricing Discounts Make The Stock Less Attractive (Archive) Pricing discounts threaten Azure and Copilot margins while Microsoft trades at peak valuations.